88 research outputs found

    āļœāļĨāļ‚āļ­āļ‡āļāļēāļĢāđƒāļŠāđ‰āđāļ­āļ›āļžāļĨāļīāđ€āļ„āļŠāļąāļ™āđƒāļ™āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒāļĄāļ·āļ­āļ–āļ·āļ­āļ•āļĢāļ§āļˆāļŠāļ­āļšāļ‚āļ™āļēāļ”āļĒāļēāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡āļŠāļđāļ‡āđ€āļ—āļĩāļĒāļšāļāļąāļšāļāļēāļĢāļ„āļģāļ™āļ§āļ“āļ”āđ‰āļ§āļĒāļĄāļ·āļ­ Effects of A Mobile Phone Application in Examining Dosage of High Alert Drugs Compared with Manual Calculation

    Get PDF
    āļšāļ—āļ„āļąāļ”āļĒāđˆāļ­ āļ§āļąāļ•āļ–āļļāļ›āļĢāļ°āļŠāļ‡āļ„āđŒ: āđ€āļžāļ·āđˆāļ­āđ€āļ›āļĢāļĩāļĒāļšāļ„āļ°āđāļ™āļ™āļ—āļĩāđˆāđ„āļ”āđ‰āđāļĨāļ°āđ€āļ§āļĨāļēāļ—āļĩāđˆāđƒāļŠāđ‰āļ•āļĢāļ§āļˆāļŠāļ­āļšāļ‚āļ™āļēāļ”āļĒāļēāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡āļŠāļđāļ‡āđƒāļ™āđƒāļšāļŠāļąāđˆāļ‡āļĒāļēāļŠāļĄāļĄāļ•āļīāļĢāļ°āļŦāļ§āđˆāļēāļ‡āļāļēāļĢāđƒāļŠāđ‰āđāļ­āļ›āļžāļĨāļīāđ€āļ„āļŠāļąāļ™āļšāļ™āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒāļĄāļ·āļ­āļ–āļ·āļ­āđāļĨāļ°āļāļēāļĢāļ„āļģāļ™āļ§āļ“āļ”āđ‰āļ§āļĒāļĄāļ·āļ­ āļ§āļīāļ˜āļĩāļāļēāļĢāļĻāļķāļāļĐāļē: āļāļēāļĢāļ§āļīāļˆāļąāļĒāđāļšāļš cross-over design āļ—āļĩāđˆāļĄāļĩ two-period (āļāđˆāļ­āļ™āđāļĨāļ°āļŦāļĨāļąāļ‡ washout period), two-sequence (āđƒāļŠāđ‰āđāļ­āļ›āļžāļĨāļīāđ€āļ„āļŠāļąāļ™āļ•āļēāļĄāļ”āđ‰āļ§āļĒāļāļēāļĢāļ„āļģāļ™āļ§āļ“āļ”āđ‰āļ§āļĒāļĄāļ·āļ­ āļāļąāļšāļāļēāļĢāļ„āļģāļ™āļ§āļ“āļ”āđ‰āļ§āļĒāļĄāļ·āļ­āļ•āļēāļĄāļ”āđ‰āļ§āļĒāđāļ­āļ›āļžāļĨāļīāđ€āļ„āļŠāļąāļ™), two-method (āļ§āļīāļ˜āļĩāļ—āļĩāđˆāđƒāļŠāđ‰āđāļ­āļ›āļžāļĨāļīāđ€āļ„āļŠāļąāļ™āđāļĨāļ°āļ§āļīāļ˜āļĩāļ„āļģāļ™āļ§āļ“āļ”āđ‰āļ§āļĒāļĄāļ·āļ­) āļāļĨāļļāđˆāļĄāļ•āļąāļ§āļ­āļĒāđˆāļēāļ‡āđ€āļ›āđ‡āļ™āđ€āļ āļŠāļąāļŠāļāļĢ 31 āļ„āļ™ āļ—āļĩāđˆāļ—āļģāļ‡āļēāļ™āđƒāļ™āđ‚āļĢāļ‡āļžāļĒāļēāļšāļēāļĨāļ—āļąāđˆāļ§āđ„āļ›āđāļĨāļ°āđ‚āļĢāļ‡āļžāļĒāļēāļšāļēāļĨāļĻāļđāļ™āļĒāđŒ 5 āđāļŦāđˆāļ‡ āļ”āļģāđ€āļ™āļīāļ™āļāļēāļĢāļ§āļīāļˆāļąāļĒāđƒāļ™āļŠāđˆāļ§āļ‡āļ˜āļąāļ™āļ§āļēāļ„āļĄ āļž.āļĻ. 2558 āļ–āļķāļ‡āļĄāļĩāļ™āļēāļ„āļĄ āļž.āļĻ. 2559 āđ‚āļ”āļĒāļŠāļĢāđ‰āļēāļ‡āđāļ­āļ›āļžāļĨāļīāđ€āļ„āļŠāļąāļ™āļŠāļģāļŦāļĢāļąāļšāđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒāļĄāļ·āļ­āļ–āļ·āļ­āļĢāļ°āļšāļšāđāļ­āļ™āļ”āļĢāļ­āļĒāļ”āđŒ āđ‚āļ”āļĒāđāļ­āļ›āļžāļĨāļīāđ€āļ„āļŠāļąāļ™āđāļŠāļ”āļ‡āļ‚āļąāđ‰āļ™āļ•āļ­āļ™āļāļēāļĢāļ„āļģāļ™āļ§āļ“āļ­āļĒāđˆāļēāļ‡āļĨāļ°āđ€āļ­āļĩāļĒāļ” āđāļĨāđ‰āļ§āļŠāļĢāđ‰āļēāļ‡āļ„āļģāļŠāļąāđˆāļ‡āđƒāļŠāđ‰āļĒāļēāđƒāļ™āđƒāļšāļŠāļąāđˆāļ‡āļĒāļēāļŠāļĄāļĄāļ•āļīāļžāļĢāđ‰āļ­āļĄāļ„āļģāļ–āļēāļĄāļ›āļĢāļ°āļāļšāđƒāļšāļŠāļąāđˆāļ‡āļĒāļēāđƒāļŦāđ‰āđ€āļ āļŠāļąāļŠāļāļĢāļ•āļĢāļ§āļˆāļŠāļ­āļšāļ‚āļ™āļēāļ”āļĒāļēāļ§āđˆāļēāđ€āļŦāļĄāļēāļ°āļŠāļĄāļŦāļĢāļ·āļ­āđ„āļĄāđˆ āđ‚āļ”āļĒāļ—āļ”āļŠāļ­āļšāļĒāļēāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡āļŠāļđāļ‡ 6 āļŠāļ™āļīāļ” āļ„āļ·āļ­ dobutamine, dopamine, potassium chloride, nicardipine, nitroglycerine āđāļĨāļ° norepinephrine āđ‚āļ”āļĒāđāļŠāļ”āļ‡āļāļēāļĢāļ„āļģāļ™āļ§āļ“āđ€āļ›āđ‡āļ™ (1) āļ­āļąāļ•āļĢāļēāļāļēāļĢāđƒāļŦāđ‰āļĒāļē (ml/hr) (2) āļ‚āļ™āļēāļ”āļĒāļēāļ—āļĩāđˆāļœāļđāđ‰āļ›āđˆāļ§āļĒāļ„āļ§āļĢāđ„āļ”āđ‰āļĢāļąāļš (Âĩg/kg/min) āđāļĨāļ° (3) āļ‚āļ™āļēāļ”āļĒāļēāļ—āļĩāđˆāđƒāļŠāđ‰āļāļąāļšāļœāļđāđ‰āļ›āđˆāļ§āļĒāļĢāļēāļĒāļ™āļąāđ‰āļ™ āđ† (mg) āđ‚āļ”āļĒāđƒāļŠāđ‰āđƒāļšāļŠāļąāđˆāļ‡āļĒāļē 7 āđƒāļšāļ—āļĩāđˆāļĄāļĩāļ„āļ§āļēāļĄāļĒāļēāļāļ‡āđˆāļēāļĒāđƒāļāļĨāđ‰āđ€āļ„āļĩāļĒāļ‡āļāļąāļ™āļŠāļģāļŦāļĢāļąāļšāđāļ•āđˆāļĨāļ°āļ§āļīāļ˜āļĩāļ•āļĢāļ§āļˆāļŠāļ­āļšāļ‚āļ™āļēāļ”āļĒāļē āđƒāļŦāđ‰āđ€āļ āļŠāļąāļŠāļāļĢāļ•āļĢāļ§āļˆāļŠāļ­āļšāļ‚āļ™āļēāļ”āļĒāļēāļ—āļąāđ‰āļ‡ 7 āđƒāļšāđāļĨāđ‰āļ§āļˆāļąāļšāđ€āļ§āļĨāļēāđāļĨāļ°āđƒāļŦāđ‰āļ„āļ°āđāļ™āļ™āļœāļĨāļāļēāļĢāļ•āļĢāļ§āļˆāļŠāļ­āļš āđ€āļ›āļĢāļĩāļĒāļšāđ€āļ—āļĩāļĒāļšāļ„āļ°āđāļ™āļ™āļ—āļĩāđˆāļ—āļģāđ„āļ”āđ‰āļ–āļđāļāļ•āđ‰āļ­āļ‡ (āđ€āļ•āđ‡āļĄ 7 āļ„āļ°āđāļ™āļ™) āđāļĨāļ°āđ€āļ§āļĨāļēāđ€āļ›āđ‡āļ™āļ§āļīāļ™āļēāļ—āļĩāđ‚āļ”āļĒ ANOVA āļœāļĨāļāļēāļĢāļĻāļķāļāļĐāļē: āļ„āļ°āđāļ™āļ™āļ•āļĢāļ§āļˆāļŠāļ­āļšāļ‚āļ™āļēāļ”āļĒāļēāļŠāđˆāļ§āļ™āļĄāļēāļāļĄāļĩāļ„āđˆāļē 6 āļ„āļ°āđāļ™āļ™āļ‚āļķāđ‰āļ™āđ„āļ› āđāļĨāļ°āđ„āļĄāđˆāļ•āđˆāļēāļ‡āļāļąāļ™āļ—āļąāđ‰āļ‡āđƒāļ™āđāļ‡āđˆ period, sequence āļŦāļĢāļ·āļ­ method āđāļ•āđˆāđ€āļ§āļĨāļēāļ—āļĩāđˆāđƒāļŠāđ‰āļ•āđˆāļēāļ‡āļāļąāļ™āļ„āļ·āļ­ āļŠāđˆāļ§āļ‡āđāļĢāļ (1,014.65 āļ§āļīāļ™āļēāļ—āļĩ) āđƒāļŠāđ‰āđ€āļ§āļĨāļēāļĄāļēāļāļāļ§āđˆāļēāļŠāđˆāļ§āļ‡āļ—āļĩāđˆāļŠāļ­āļ‡ (852.90 āļ§āļīāļ™āļēāļ—āļĩ) āļ­āļĒāđˆāļēāļ‡āļĄāļĩāļ™āļąāļĒāļŠāļģāļ„āļąāļāļ—āļēāļ‡āļŠāļ–āļīāļ•āļī (P-value = 0.002) āđāļĨāļ°āđāļ­āļ›āļžāļĨāļīāđ€āļ„āļŠāļąāļ™ (649.06 āļ§āļīāļ™āļēāļ—āļĩ) āļ™āđ‰āļ­āļĒāļāļ§āđˆāļēāļāļēāļĢāļ„āļģāļ™āļ§āļ“āļ”āđ‰āļ§āļĒāļĄāļ·āļ­ (1,218.48 āļ§āļīāļ™āļēāļ—āļĩ) āļ­āļĒāđˆāļēāļ‡āļĄāļĩāļ™āļąāļĒāļŠāļģāļ„āļąāļāļ—āļēāļ‡āļŠāļ–āļīāļ•āļī (P-value < 0.001) āļŠāļĢāļļāļ›: āđāļ­āļ›āļžāļĨāļīāđ€āļ„āļŠāļąāļ™āļšāļ™āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒāļĄāļ·āļ­āļ–āļ·āļ­āļŠāđˆāļ§āļĒāđƒāļŦāđ‰āļāļēāļĢāļ•āļĢāļ§āļˆāļŠāļ­āļšāļ‚āļ™āļēāļ”āļĒāļēāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡āļŠāļđāļ‡āđ„āļ”āđ‰āļ”āļĩāļžāļ­ āđ† āļāļąāļšāļāļēāļĢāļ„āļģāļ™āļ§āļ“āļ”āđ‰āļ§āļĒāļĄāļ·āļ­ āđāļ•āđˆāļĨāļ”āđ€āļ§āļĨāļēāļāļēāļĢāļ—āļģāļ‡āļēāļ™āđ„āļ”āđ‰āļĄāļēāļ āļ„āļģāļŠāļģāļ„āļąāļ: āđāļ­āļ›āļžāļĨāļīāđ€āļ„āļŠāļąāļ™, āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒāļĄāļ·āļ­āļ–āļ·āļ­, āļ•āļĢāļ§āļˆāļŠāļ­āļšāļ‚āļ™āļēāļ”āļĒāļē, āļĒāļēāļ„āļ§āļēāļĄāđ€āļŠāļĩāđˆāļĒāļ‡āļŠāļđāļ‡ ...  Abstract Objectives: To compare scores and times in examining prescribed doses of high-alert drugs (HADs) in prescriptions between mobile phone application and manual calculation. Methods: This cross-over study tested two-period, two-sequence (application use followed by manual calculation and vice versa) and two-method (application and manual calculation) effects on scores and time in examining prescribed doses of 6 HADs (dobutamine, dopamine, potassium chloride, nicardipine, nitroglycerine and norepinephrine). Sample was 31 pharmacists working in 5 general hospitals and medical centers. The study was conducted from December 2015 to March 2016. The developed android application displayed all calculation steps. With each method, pharmacists examined (1) rate of administration (ml/hr) (2) dose per kg per min and (3) total dose (mg) in 7 prescriptions along with questions with comparable difficulty. Scores (total of 7 points) and time (in seconds) were recorded and statistically tested using ANOVA. Questionnaire on desirable characteristics the application was filled at the end of the experiment and presented as percentage. Results: Total scores on examining the prescribed doses were mostly more than 6 points with no statistical difference regarding differences in period, sequence or method. Time used in the first period (1,014.65 seconds) was longer than that in the second period (852.90 seconds) with statistical significance (P-value = 0.002), and that with application use (649.06 seconds) was shorter than that with manual calculation (1,218.48 seconds) with statistical significance (P-value < 0.001). Conclusion: Mobile phone application offered performance in examining prescribed doses of HADs comparable to that of manual calculation but with a shorter time. Keywords: application, mobile phone, dose examination, high alert drug

    Is The “See and Treat” Approach Appropriate for Management of Women with Abnormal Cervical Cytology in Thailand?

    Get PDF
    At present, the “see and treat” approach for women with abnormal cervical cytology is widely accepted. It has been proven to be more cost-effectiveness than conventional management, making it particularly attractive for many regions in Thailand where resources are limited and poor patients’ compliance is expected. However, the main disadvantage of the “see and treat” approach is the risk of overtreatment. National Health Service (NHS) guidelines recommend that the overtreatment rate in the “see and treat” approach must be less than 10%. The overtreatment rate appears to be acceptable if the “see and treat” approach is carried out in women with high-grade squamous intraepithelial lesion (HSIL) cytology or in women with lesser grades of smear abnormality whose colposcopic findings suggest high-grade disease

    Adenocarcinoma in situ of the uterine cervix

    Get PDF
    Adenocarcinoma in situ (AIS) of the uterine cervix has been acknowledged as a precursor lesion of invasive adenocarcinoma. AIS is histologically characterized by the presence of endocervical gland lined by atypical endocervical epithelium resembling the cells of adenocarcinoma but has no evidences of stromal invasion. AIS occurs within the endocervical clefts, it is difficult to screen cytologically. Incorporating high-risk HPV-DNA testing into cytologic screening could better identify AIS lesion. For definitive diagnosis of AIS, cervical conization either with knife, electrical loop, or laser is required to ensure the exclusion of coexisting invasive adenocarcinoma. Hysterectomy remains the most preferred method of definite treatment. Conservative management by conization alone is only acceptable for whom preservation of fertility is an issue. The occurrences of recurrent or persistent disease for women treated for AIS are mostly noted during the first 3 years of follow-up emphasizing the necessity of extensive surveillance in this period

    Evaluation of Completeness of Operative Records in Women Undergoing Gynecologic Surgery at Chiang Mai University Hospital

    Get PDF
    Objective: To evaluate the completeness of operative records at the general gynecologic surgery unit using the Good Surgical Practice (GSP) 2008 guidelines as a gold standard.Materials and methods: The operative records of women undergoing gynecologic operation at Chiang Mai University Hospital between January and July 2009 were reviewed. According to GSP 2008, the operative record should include all of the following data: (1) date and time of operation; (2) types of surgery ; (3) name of the operating surgeon and assistant; (4) operative procedure carried out; (5) incision; (6) operative diagnosis; (7) operative findings; (8) operative complications; (9) any extra procedure performed and its reason; (10) details of tissue removed, added or altered; (11) identification of any prosthesis used including serial numbers of such materials; (12) details of closure technique; (13) postoperative care instruction and (14) a signatureResults: During the study period, the medical records of 232 women who underwent gynecologic surgery were reviewed to determine the quality of the operative record. Postoperative care instruction was completely recorded in all operative notes (100%). Only 2 of the 14 items failed above 10% including details of incision (10.3%) and details of closure technique (12.9%). The signature was absent in 13 operative notes (5.6%).Conclusion: The evaluation results of operative records as per GSP 2008 guidelines in this study appear to be favorable. The details of incision and closure technique should be improved and periodic audit is required to assure that these standards are maintained

    Risk Factors for Development of Rhegmatogenous Retinal Detachment in Patients with Uveitis

    Get PDF
    Purpose: To describe risk factors for development of rhegmatogenous retinal detachment (RRD) in patients with uveitis. Methods: We performed a retrospective review of 411 consecutive human immunodeficiency virus-negative patients with uveitis (571 affected eyes) and report on prevalence, risk factors and visual outcomes of patients with RRD. Results: Prevalence of RRD was 7% of all patients with uveitis. Multivariate analysis revealed that posterior uveitis and panuveitis were associated with RRD (P = 0.001). Strong association between RRD development and infectious uveitis was also observed (P = 0.009). Acute retinal necrosis (ARN) was firmly associated with RRD development (P = 0.016). Although anatomical success was obtained, functional outcome was poor. Poor visual outcomes at 6-month and 1-year follow-up were associated with initial VA < counting fingers (P = 0.05, P = 0.044). Conclusions: Prevalence of RRD in uveitis was 7% and development of RRD was encountered in posterior and panuveitis. Infectious uveitis (specifically ARN) formed a high risk for RRD
    • â€Ķ
    corecore